Status:
UNKNOWN
Role of Parasitic Infection in Inflammatory Bowel Disease and Irritable Bowel Syndrome
Lead Sponsor:
Assiut University
Conditions:
Parasite IBS IBD
Eligibility:
All Genders
17-69 years
Brief Summary
Role of parasitic infection in Inflammatory bowel disease and Irritable bowel The burden of the parasitic disease is in-direct relation with the health and nutritional status of the host, inducing not...
Detailed Description
1. Detect the prevalence of parasite/s associated with Inflammatory bowel diseases (IBD) and Irritable bowel syndrome (IBS) in comparison with control subjects. 2. Evaluating the effect of the parasit...
Eligibility Criteria
Inclusion
- Diagnosis of IBD will be confirmed using
- standard clinical,
- endoscopic,
- radiographic and4 pathological criteria according to the Montreal classification of the extent and severity of IBD
- Diagnosis of IBS will depend on Rome IV criteria
- Recurrent abdominal pain on average at least 1 day/week in the last 3 months,
- associated with two or more of the following criteria:
- Related to defecation;
- Associated with a change in the frequency of stool and/ or Associated with a change in the form (appearance) of stool.
Exclusion
- any patient who received antipiotic or antiparasitic drug within the past 4 weeks
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04760600
Start Date
June 1 2021
End Date
June 1 2024
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marina Gamil Shwqi
Asyut, Egypt